Evaluation of atovaquone in the treatment of patients with uncomplicated Plasmodium falciparum malaria.
Chiodini PL., Conlon CP., Hutchinson DB., Farquhar JA., Hall AP., Peto TE., Birley H., Warrell DA.
The activity of atovaquone in patients with oligosymptomatic Plasmodium falciparum malaria was assessed in an open, non-comparative clinical study. The patients showed a good clinical response, but there was a high rate of recrudescence. The activity of atovaquone in combination with another antimalarial agent should be investigated.